Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03855800 · ClinicalTrials.gov registry record · NA

Molecular Detection of Advanced Neoplasia in Pancreatic Cysts

A NA study of Pancreas Cyst, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
800
Enrollment target
1
Study location

NCT03855800 is a NA study of Pancreas Cyst that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 800 participants, below the 7,094-participant average among 3 other Pancreas Cyst trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03855800, a NA study of Pancreas Cyst, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
800 participants
Enrollment target
1
Study location

Study Summary

Researchers are trying to find out whether new tests ("biomarkers") of blood, stool, pancreas cyst fluid, or pancreas juice can be used to diagnose malignant or pre-malignant changes in pancreas cysts.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Blood, stool, pancreatic juice and cyst fluid collection
  • PROCEDURE Pancreatic Surgery
  • PROCEDURE Endoscopy Exam

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2018-05-11
Est. Completion 2030-12-30
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT03855800

The ClinicalTrials.gov registry entry for NCT03855800 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,094-participant average among 3 other Pancreas Cyst trials with a reported enrollment target (89% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pancreas Cyst appearing as the primary indexed condition, and to 3 interventions - of which Blood, stool, pancreatic juice and cyst fluid collection is the first listed.

NCT03855800 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03855800 about?

NCT03855800 is a clinical study titled "Molecular Detection of Advanced Neoplasia in Pancreatic Cysts". Researchers are trying to find out whether new tests ("biomarkers") of blood, stool, pancreas cyst fluid, or pancreas juice can be used to diagnose malignant or pre-malignant changes in pancreas cysts.

What is the current status of trial NCT03855800?

This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2018-05-11. Estimated completion is 2030-12-30.

What conditions does trial NCT03855800 study?

This clinical trial studies the following conditions: Pancreas Cyst.

What interventions are being tested in trial NCT03855800?

The interventions under investigation include: Blood, stool, pancreatic juice and cyst fluid collection (DIAGNOSTIC_TEST), Pancreatic Surgery (PROCEDURE), Endoscopy Exam (PROCEDURE).

Who is sponsoring clinical trial NCT03855800?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03855800 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pancreas Cyst

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.